The expression rate of SHP2 is high and closely correlated to lymphnode metastasis in NSCLC, which implies the occurrence and development of lung cancer may be related to SHP2, and SHP2 may be a new marker and therapeutic targets for lung cancer. The gene discussed is PTPN11; the disease is lung cancer.